glp-1 side effects blindness Doctor Explains GLP 1 Risk (Should You Be Worried?) Can Ozempic-like Drugs Cause Blindness?

Clinical studies, including the STEP 1 trial extension, have demonstrated that patients who discontinue GLP-1 receptor agonists often regain a substantial portion of the weight they lost, sometimes within months

In addition to the drugs potential direct implications in treating those conditions, employers also are considering the possible longer-term health effects of treating obesity, such as reduced risk of chronic conditions which can lower health costs in the future given the prevalence of obesity and the cost of not treating it, Schuman said

GLP-1 agonists are not a replacement for antihypertensive therapy but may complement it

Eligibility criteria Eligible randomised controlled trials enrolled adults (18-65 years old) with type 2 diabetes who received GLP-1RAs, with a follow-up duration of at least 12 weeks

Available at: (Accessed 2023 20th of March)

All of the above constructs were generated in pFastBac and pcDNA3.1 vectors for protein expression in insect cells and functional assays in mammalian cells, respectively